Abstract: Data is processed in a telecommunications network. First and second notifications are received, via an input interface, from first and second Charging Trigger Functions, CTFs, in the telecommunications network. The first and second notifications relate to network resource usage in the telecommunications network. A scalable transformation function is used to transform data derived from the first and second notifications into a first usage detail report in a first detail report format and a second usage detail report in a second, different detail report format. The first and second usage detail reports are output, via an output interface, to at least one recipient system.

Abstract: Data is processed in a telecommunications network. First and second notifications are received, via an input interface, from first and second Charging Trigger Functions, CTFs, in the telecommunications network. The first and second notifications relate to network resource usage in the telecommunications network. A scalable transformation function is used to transform data derived from the first and second notifications into a first usage detail report in a first detail report format and a second usage detail report in a second, different detail report format. The first and second usage detail reports are output, via an output interface, to at least one recipient system.

Abstract: The invention relates to a processor for working on histological samples. The processor has an inlet for the insertion of a fixing container, particularly a closed fixing container, with the samples located in the latter.

Abstract: An apparatus for holding a tissue sample having a retaining member with a first tissue engaging surface and at least one biasing element. The first tissue engaging surface is moveably attached to the retaining member. The apparatus also has a base comprising a second tissue engaging surface which is configured to engage the retaining member to form an interior area with the first and second tissue engaging surfaces facing each other. The apparatus also has a retracting member connected to the retaining member which is configured to retract the first tissue engaging surface and compress the biasing element to form a gap between the tissue sample and one of the first tissue engaging surface and the second tissue engaging surface.

Abstract: The invention relates to a processor for working on histological samples. The processor has an inlet for the insertion of a fixing container, particularly a closed fixing container, with the samples located in the latter.

Abstract: An apparatus for holding a tissue sample having a retaining member with a first tissue engaging surface and at least one biasing element. The first tissue engaging surface is moveably attached to the retaining member. The apparatus also has a base comprising a second tissue engaging surface which is configured to engage the retaining member to form an interior area with the first and second tissue engaging surfaces facing each other. The apparatus also has a retracting member connected to the retaining member which is configured to retract the first tissue engaging surface and compress the biasing element to form a gap between the tissue sample and one of the first tissue engaging surface and the second tissue engaging surface.

Abstract: A shock absorber assembly includes a motion damping means that is filled with a fluid in operation and has a pair of relatively moveable parts (12, 14) and valve means (26) permitting flow of the fluid between the parts. The parts comprise a first part (12) and a second part (14) in which the first part is receivable whereby the parts are arranged for relative retracting and extending movement during which fluid is forced through the valve means (26) at respective predetermined controlled flow rates so as to dampen the movement. The relatively moveable parts contain respective primary chambers (24, 29) for the fluid. The first part is substantially smaller in cross-section than the second part to define an intermediate chamber (52) about the first part within the second part. Lateral port means (56) communicates the intermediate chamber (52) and the primary chamber (24) of first part (12).

Abstract: There is disclosed a serially connectable device (200) for acting as a master device to control power usage by itself and one or more other serially connectable devices comprising a power input port (208) through which power is supplied to the serially connectable device (200), an output serial power connector (206) for supplying power and power control signals to any other serially connectable device or devices connected via said first serial power connector to the supply of power received through said power input port (200), and a microcontroller (216) for controlling power usage by one or more internal components (218,222) of the serially connectable device and for producing control signals to control power usage by any other device or devices connected in series with said serially connectable device.

Abstract: A suspension unit (110) for a suspension system has an accumulator (12) for holding and maintaining a fluid such as a gas under pressure. The accumulator is associated with a motion damping unit (114) that is filled with a fluid, such as an oil, in operation. The accumulator includes a floating piston (122) that separates a first chamber (120) in which is stored the pressurised gas, and a second chamber (124) for storing the other fluid under pressure. A third chamber (128) in the motion damping unit (114) is in fluid flow communication with the second chamber (124) of said accumulator through valve means (126) controlling the flow of fluid between the chambers.

Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

Abstract: Compounds of formula (I): wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents —(CRnaRnb)n—; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5; R2 represents unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl; R3 and R4 each independently represent hydrogen or C1-6alkyl; R7 represents hydrogen or C1-6alkyl; R8 represents hydrogen or C1-6alkyl; and salts and solvates thereof; are CCR3 antagonists and are thus indicated to be useful in therapy.

Abstract: Compound of formula (I): and salts and solvates thereof, a process for its preparation, pharmaceutical formulations containing it and its use in therapy.

Abstract: An abrasion resistant acrylic composition comprises at least 70% w/w of the residues of at least one polmerisable acrylic monomer, 0.2-5% w/w of a finely divided compound comprising at least one oxide selected from silicon, titanium, zirconium and aluminum oxides, and 0.2-25% w/w of at least one linking compound which is miscible with said polymerisable acrylic monomer and which is capable of bonding to the surface of the oxide compound. The acrylic composition may be thermoformed while retaining its abrasion resistant surface properties.